CompletedNCT00162903
Nitric Oxide, Endothelin-1, and the Patency of Ductus Arteriosus in Preterm Infants
Studying Arterial duct anomaly
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Taiwan University Hospital
- Principal Investigator
- Wu Shiun Hsieh, M.DNational Taiwan University Hospital
- Enrollment
- 80 enrolled
- Eligibility
- 0-1 years · All sexes
- Timeline
- 2002 – 2002
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00162903 on ClinicalTrials.govOther trials for Arterial duct anomaly
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGNCT06950164Dynamic Changes of Ductus Arteriosus in < 31 Weeks Preterm Infants: an Observational StudyDaping Hospital and the Research Institute of Surgery of the Third Military Medical University
- RECRUITINGNCT06658496PDA for Kidneys StudyUniversity of Wisconsin, Madison
- RECRUITINGNCT06646250NeoDoppler: New Ultrasound Technology for Continuous Monitoring of Cerebral Circulation PilotSt. Olavs Hospital
- RECRUITINGPHASE2NCT07143201Precision Dosing of Oral Ibuprofen for PDA, A Pilot RCTHamilton Health Sciences Corporation
- RECRUITINGNCT05264753Post Marketing Clinical Follow Up Study to Evaluate Efficacy and Safety of the Occlutech PDA Occluder in Patients With Patent Ductus Arteriosus DefectsOcclutech International AB
- ACTIVE NOT RECRUITINGNCT04371081Amplatzer Piccolo Occluder Japan Post-marketing Database SurveillanceAbbott Medical Devices
- ENROLLING BY INVITATIONNANCT04667455Improving Care for Children With Congenital Heart Disease.Lund University Hospital
- ACTIVE NOT RECRUITINGNCT03782610Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated OutcomesNationwide Children's Hospital